Inventor · disambiguated record
Ming Qian
Also filed as: QIAN MING · QIAN MING DIANA
9 granted patents·6 pending applications·78 citations·filing 2000–2023
87Inventor score
Top patents by PatentIndex Score
15 records- 0191US7750122B2Anti-TrkB monoclonal antibodies and uses thereofWYETH LLC·Filed 2006·Granted Jul 6, 2010·28 cites·27 claims
- 0290US11485742B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2020·Granted Nov 1, 2022·2 cites·22 claims
- 0389US11548865B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2020·Granted Jan 10, 2023·2 cites·29 claims
- 0488US7101549B2Glycoprotein VI and uses thereofMILLENNIUM PHARM INC·Filed 2004·Granted Sep 5, 2006·16 cites·16 claims
- 0588US6989144B1Glycoprotein VI antibodies and uses thereofMILLENNIUM PHARM INC·Filed 2000·Granted Jan 24, 2006·22 cites·16 claims
- 0687US7597888B2Glycoprotein VI and uses thereofMILLENNIUM PHARM INC·Filed 2006·Granted Oct 6, 2009·8 cites·16 claims
- 0777US2024140959A12-azaspiro[3.4]octane derivatives as m4 agonistsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0874US11820778B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2022·Granted Nov 21, 2023·0 cites·30 claims
- 0970US12122761B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2022·Granted Oct 22, 2024·0 cites·25 claims
- 1059US2025145600A12-((4-((s)-2-(4-chloro-2-fluorophenyl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((s)-oxetan-2-yl)methyl)-1h-imidazole derivatives as activators of the glp1 receptor for the treatment of obesityNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1154US2024182456A12-((4-((s)-2-(4-chloro-2-fluorophenyl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((s)-oxetan-2-yl)methyl)-1h-imidazole derivatives as activators of the glp1 receptor for the treatment of obesityNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1250US2004001826A1Glycoprotein VI and uses thereofMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 1341US2011150893A1Anti-trkb monoclonal antibodies and uses thereofWYETH LLC·Filed 2010·Application pending·0 cites
- 1439US9255093B2Polycyclic HERG activatorsBEBERNITZ GREGORY RAYMOND·Filed 2015·Granted Feb 9, 2016·0 cites·16 claims
- 1539US2016108025A1Polycyclic herg activatorsBEBERNITZ GREGORY RAYMOND·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →